Cargando…
Disease-modifying agents in multiple sclerosis
Since 1993, six disease-modifying therapies for multiple sclerosis (MS) have been proven to be of benefit in rigorous phase III clinical trials. Other agents are also available and are used to treat MS, but definitive data on their efficacy is lacking. Currently, disease-modifying therapy is used fo...
Autor principal: | Coyle, P. K. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824955/ https://www.ncbi.nlm.nih.gov/pubmed/20182575 http://dx.doi.org/10.4103/0972-2327.58280 |
Ejemplares similares
-
Cerebrospinal fluid in multiple sclerosis
por: Rammohan, Kottil W.
Publicado: (2009) -
The symptomatic management of multiple sclerosis
por: Schapiro, Randall T.
Publicado: (2009) -
Rehabilitation challenges in multiple sclerosis
por: Burks, Jack S., et al.
Publicado: (2009) -
The diagnosis of multiple sclerosis and the clinical subtypes
por: Hurwitz, Barrie J.
Publicado: (2009) -
Management of acute exacerbations in multiple sclerosis
por: Ontaneda, Daniel, et al.
Publicado: (2009)